Liver injury in COVID-19: management and challenges

Hussin A. Rothana, Siddappa N. Byrareddy

Liver injury in COVID-19: management and challenges

Chao Zhang, Lei Shi, Fu-Sheng Wang

Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430. doi: 10.1016/S2468-1253(20)30057-1. Epub 2020 Mar 4.

ABSTRACT

SARS-CoV-2 shares 82% genome sequence similarity to SARS-CoV and 50% genomic sequence homology to the Middle East respiratory syndrome coronavirus (MERS-CoV). All three coronaviruses are known to cause severe respiratory symptoms. Liver failure has been reported in up to 60% of patients with SARS and has also been reported in patients infected with MERS-CoV.

Liver damage in patients with coronavirus infections could be caused directly by viral infection of liver cells.

Approximately 2 to 10% of COVID-19 patients experience diarrhea, and SARS-CoV-2 RNA has been detected in stool and blood samples. This evidence implicates the possibility of viral exposure in the liver.